(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Curl Up With Some Hot Chocolate And Watch Mighty Car Mods Explore Japan In A Honda City Turbo II - 2A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
- 341 Young Men Die in South Africa After Circumcision Initiation
- 4Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- 52024 Moving Styles for Kitchen Redesigns
- Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- Agricultural drones are taking off globally, saving farmers time and money
- Do-It-Yourself Home Style on a Careful spending plan: Imaginative Thoughts and Tasks
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Climbing Mount Everest: An Individual Victory
- Easy to understand Tech: Cell phones for Old in 2024
- Are protests pushing Iran's Islamic regime toward a tipping point?
- Instructions to Pick the Ideal SUV Size for Seniors
